Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 10, Number 1—January 2004

Research

Severe Acute Respiratory Syndrome–associated Coronavirus in Lung Tissue

Tony Mazzulli*†‡, Gabriella A. Farcas‡§, Susan M. Poutanen*†‡, Barbara M. Willey*†, Donald E. Low*†‡, Jagdish Butany†‡¶, Sylvia L. Asa†‡¶, and Kevin C. Kain‡§1Comments to Author 
Author affiliations: *Mount Sinai Hospital, Toronto, Ontario, Canada; †Toronto Medical Laboratories, Toronto Ontario, Canada; ‡University of Toronto, Toronto, Ontario, Canada; §Toronto General Hospital, Toronto, Ontario, Canada; ¶University Health Network, Toronto, Ontario, Canada

Main Article

Figure

RealArt HPA-Coronavirus LightCycler (RealArt HPA Coronavirus RT-PCR) reverse transcription-polymerase chain reaction (PCR) Assay results. PCR results from 5 μL RNA are displayed in channel F1/F2 of the LightCycler instrument (A). Four quantification standards are included in the assay to generate a standard curve (B). An internal control, added at the RNA isolation stage, is used to monitor both the quality of the RNA isolation as well as possible PCR inhibition (C).

Figure. RealArt HPA-Coronavirus LightCycler (RealArt HPA Coronavirus RT-PCR) reverse transcription-polymerase chain reaction (PCR) Assay results. PCR results from 5 μL RNA are displayed in channel F1/F2 of the LightCycler instrument (A). Four quantification standards are included in the assay to generate a standard curve (B). An internal control, added at the RNA isolation stage, is used to monitor both the quality of the RNA isolation as well as possible PCR inhibition (C).

Main Article

1Drs. Mazzulli and Farcas contributed equally to the manuscript. All authors jointly conceived and designed the study and wrote the report. Gabriella A. Farcas performed the majority of the reverse transcription-polymerase chain reaction assays.

The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.

Ahead Of Print

GO

Past Issues

GO

LATEST PODCAST

Hepatitis A Virus in Transplants— (Length: 11:33)

CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

Related Information

Additional Resources

CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

TOP